[HTML][HTML] Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review
N Singh, A Miner, L Hennis, S Mittal - Cancer drug resistance, 2021 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and has an
exceedingly low median overall survival of only 15 months. Current standard-of-care for …
exceedingly low median overall survival of only 15 months. Current standard-of-care for …
Potential strategies overcoming the temozolomide resistance for glioblastoma
S Jiapaer, T Furuta, S Tanaka, T Kitabayashi… - Neurologia medico …, 2018 - jstage.jst.go.jp
Glioblastoma (GBM) is a highly malignant type of primary brain tumor with a high mortality
rate. Although the current standard therapy consists of surgery followed by radiation and …
rate. Although the current standard therapy consists of surgery followed by radiation and …
Ketogenic diet in cancer prevention and therapy: molecular targets and therapeutic opportunities
Although cancer is still one of the most significant global challenges facing public health, the
world still lacks complementary approaches that would significantly enhance the efficacy of …
world still lacks complementary approaches that would significantly enhance the efficacy of …
microRNAs (miRNAs) in glioblastoma multiforme (GBM)—recent literature review
M Makowska, B Smolarz, H Romanowicz - International Journal of …, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most common, malignant, poorly promising primary
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …
brain tumor. GBM is characterized by an infiltrating growth nature, abundant vascularization …
The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations
A Buruiană, ȘI Florian, AI Florian, TL Timiș… - International journal of …, 2020 - mdpi.com
Glioblastoma (GBM) consists of a heterogeneous collection of competing cellular clones
which communicate with each other and with the tumor microenvironment (TME) …
which communicate with each other and with the tumor microenvironment (TME) …
[HTML][HTML] Role of microRNAs in glioblastoma
Glioblastoma is the most common and aggressive primary human brain cancer. MicroRNAs
(miRNAs) are a set of small endogenous non-coding RNA molecules which play critical …
(miRNAs) are a set of small endogenous non-coding RNA molecules which play critical …
[HTML][HTML] MicroRNAs as prognostic markers and therapeutic targets in gliomas
A Sufianov, S Begliarzade, T Ilyasova, Y Liang… - Non-coding RNA …, 2022 - Elsevier
Gliomas are invasive brain tumors characterized by high rates of recurrence and mortality.
Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its …
Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogenicity and its …
Dissecting tumor antigens and immune subtypes of glioma to develop mRNA vaccine
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …
used to develop personalized immunotherapy for cancer. However, its application against …
microRNA-181 serves as a dual-role regulator in the development of human cancers
MicroRNAs (miRNAs) as the regulatory short noncoding RNAs are involved in a wide array
of cellular and molecular processes. They negatively regulate gene expression and their …
of cellular and molecular processes. They negatively regulate gene expression and their …
H19 promotes non‐small‐cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR‐17
Z Huang, W Lei, HB Hu, H Zhang… - Journal of cellular …, 2018 - Wiley Online Library
LncRNAs can exhibit crucial roles in the development of multiple cancers, including non‐
small cell lung cancer (NSCLC). Currently, we investigated the role of lncRNA H19 in …
small cell lung cancer (NSCLC). Currently, we investigated the role of lncRNA H19 in …